Getein Biotech, Inc (SHA:603387)
9.09
-0.25 (-2.68%)
May 21, 2026, 3:00 PM CST
Getein Biotech Company Description
Getein Biotech, Inc researches, develops, produces, and sells in vitro diagnostic products in China and internationally.
The company provides diagnostic reagents and analyzers; calibrators; reagent raw materials, such as monoclonal and polyclonal antibodies, antigen, antiserum, and microsphere; and cardiac marker, inflammation, renal function, coagulation, thyroid function, fertility, diabetes care, and thrombus products.
It also offers products in the area of cardiovascular, inflammatory, diabetes, fertility, renal, liver, and others.
The company was founded in 2002 and is headquartered in Nanjing, China.
Getein Biotech, Inc
| Country | China |
| Founded | 2002 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 1,947 |
| CEO | Enben Su |
Contact Details
Address: No.9 Bofu Road Nanjing China | |
| Phone | 86 25 6856 8588 |
Stock Details
| Ticker Symbol | 603387 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100002RR9 |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Enben Su | Chairman and GM |
| Wen Ni | Accounting Supervisor, Financial Director and Director |
| Tingting Kong | Deputy GM and Director |
| Bin Yan | Deputy GM and Director |
| Cong Liu | Secretary of the Board of Directors |